have become more digitally savvy during CV-19 and state that their engagement preference has sustainably changed
What's the measurable opportunity of this change for pharma firms? How much customer response, future sales and profits can they gain by optimizing their customer engagement model and channel mix?
offers a useful prediction. This burns money.
helps pharma firms to predict how customers respond to their promotional activities
Where are clusters of customers who increase prescriptions in response to higher activity levels?
How much field force per cluster to maximize sales? Which channel mix maximizes customer response? Which product mix maximizes customer response?...
Where are single remote responsive customers? How can they be served virtually?
What is the overall impact on future sales and profits?
Results from initial study with 1.7 bn UK data
1. Higher customer response
2. +5-10% profit upside
3. 60-90% less planning work